cardiomyopathy - Nursing Case Study

Pathophysiology

• Primary mechanism: In cardiomyopathy, the heart muscle becomes weakened due to genetic mutations, leading to structural and functional abnormalities. This impairs the heart's ability to pump blood effectively, often resulting in heart failure symptoms.

• Secondary mechanism: Chronic stress on the heart from hypertension or ischemic heart disease can cause compensatory hypertrophy or dilation. Over time, these adaptations fail, causing further deterioration of cardiac function.

• Key complication: Impaired cardiac output leads to congestion in the lungs and periphery, contributing to symptoms like dyspnea and edema, and increasing the risk of arrhythmias and thromboembolic events.

Patient Profile

Demographics:

55-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, family history of heart disease

• Current medications: Lisinopril, Metformin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and fatigue

• Key symptoms: Palpitations, mild chest pain, swelling in the legs

• Vital signs: Blood pressure 145/90 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

During the initial assessment, the nurse noted several significant findings that warranted further investigation. The patient's jugular venous pressure was elevated, indicating possible fluid overload and right-sided heart failure. Auscultation of the heart revealed an irregular rhythm with frequent premature beats, suggesting the presence of arrhythmias likely related to the cardiomyopathy. Lung auscultation indicated bilateral crackles at the bases, consistent with pulmonary congestion. Peripheral edema was observed, with pitting present up to the mid-calf bilaterally. The patient's skin was cool to the touch, and capillary refill was slightly delayed at 3 seconds, pointing to compromised peripheral circulation.

Laboratory results revealed elevated B-type natriuretic peptide (BNP) levels, a marker of heart failure, and a slightly increased creatinine level, indicating potential renal involvement due to decreased cardiac output. Electrolyte imbalances were also present, with low potassium and magnesium levels, increasing the risk for arrhythmias. An echocardiogram performed the same day showed a reduced ejection fraction of 35%, supporting the diagnosis of systolic dysfunction secondary to the cardiomyopathy. These findings suggest the heart's inability to maintain adequate circulation, corroborating the presenting symptoms of dyspnea and fatigue.

Given these assessment findings and diagnostic results, the medical team initiated a treatment plan aimed at optimizing cardiac function and managing symptoms. Diuretics were prescribed to address fluid overload, and the patient's antihypertensive regimen was adjusted to better control blood pressure and reduce cardiac workload. Additionally, electrolyte repletion was started to correct imbalances and minimize arrhythmogenic risk. Despite these interventions, the patient experienced a sudden onset of severe shortness of breath and worsening chest pain, prompting immediate re-evaluation and escalation of care. This change in status suggests a potential acute complication, such as decompensated heart failure or a new ischemic event, necessitating urgent diagnostic workup and possible advanced interventions to stabilize the patient.

Section 2

As the medical team responded to the patient's sudden deterioration, further assessment revealed critical changes in the patient's status. Vital signs indicated significant hypotension, with a blood pressure of 82/54 mmHg, and tachycardia with a heart rate of 122 beats per minute. The patient was visibly distressed, exhibiting labored breathing and using accessory muscles for respiration. Oxygen saturation had dropped to 88% on room air, necessitating supplemental oxygen to maintain adequate SpO2 levels. Despite these measures, the patient remained dyspneic, prompting concerns for acute respiratory failure secondary to worsening heart failure or a possible acute coronary syndrome.

An urgent electrocardiogram (ECG) was performed, which showed ST-segment depression in the lateral leads, raising suspicion for myocardial ischemia. Concurrently, troponin levels were drawn and found to be elevated, confirming myocardial injury. These findings, combined with the patient's clinical presentation, suggested an acute exacerbation of heart failure with possible ischemic contribution. The team initiated high-flow oxygen and considered advanced cardiac monitoring to closely observe for further arrhythmias or hemodynamic instability.

Recognizing the potential for cardiogenic shock, the medical team quickly escalated care, initiating an intravenous infusion of inotropes to support the heart's contractility and improve perfusion to vital organs. A repeat echocardiogram was ordered to assess for any new structural changes, such as left ventricular thrombus or further reduction in ejection fraction. Given the complexity of the case, a cardiology consult was requested for potential revascularization options and optimization of heart failure management. The patient's status underscored the need for continuous monitoring and a multidisciplinary approach to stabilize and address the underlying cardiac pathology effectively.

Section 3

As the medical team continued to monitor the patient's condition, initial responses to the interventions provided mixed outcomes. The intravenous inotropes appeared to improve hemodynamic stability slightly, with the patient's blood pressure rising to 94/58 mmHg, offering a temporary reprieve from severe hypotension. Heart rate stabilized at approximately 110 beats per minute, yet the patient's respiratory distress persisted, despite high-flow oxygen therapy. Repeat arterial blood gas analysis showed persistent respiratory acidosis, with a pH of 7.32 and elevated pCO2 levels at 58 mmHg, highlighting ongoing challenges in respiratory compensation and the potential need for mechanical ventilation support.

The echocardiogram results revealed a reduced ejection fraction of 25%, down from 35% noted in prior assessments, indicating worsening systolic dysfunction. No new structural abnormalities were identified, such as thrombus formation in the left ventricle, but there was notable global hypokinesis. These findings reinforced the suspicion of cardiogenic shock and myocardial ischemia as driving factors in the patient's deteriorating status. The elevated troponin levels, alongside these echocardiographic changes, emphasized the need for urgent revascularization strategies to prevent further myocardial damage.

Despite the initial stabilization in hemodynamics, the patient's condition took another turn as signs of renal impairment emerged, evidenced by rising creatinine levels, now at 2.1 mg/dL, suggesting acute kidney injury likely secondary to poor perfusion. This complication necessitated a careful reassessment of fluid management and inotropic support to balance cardiac output with renal perfusion. The cardiology team, now fully engaged, discussed possible percutaneous coronary intervention to address the ischemic component, while nephrology was consulted to assist in managing the evolving renal insufficiency. This multidisciplinary collaboration aimed to address the interplay of cardiac and renal dysfunction, emphasizing the complexity of the patient's acute decompensation.

Section 4

As the team continued to manage the patient's complex condition, attention was drawn to the patient's fluid status, given the emerging renal impairment and the need for careful balancing of inotropic therapy. The fluid balance chart indicated a positive balance, with signs of peripheral edema becoming more evident. Despite this, the patient's urine output had decreased significantly to less than 20 mL/hour, raising concerns about worsening renal perfusion and potential fluid overload. A repeat laboratory workup showed a further increase in creatinine to 2.5 mg/dL and a blood urea nitrogen (BUN) level of 48 mg/dL, confirming the progression of acute kidney injury.

In light of these developments, the nephrology team decided to initiate continuous renal replacement therapy (CRRT) to support renal function while carefully managing fluid status. This intervention aimed to provide gentle fluid removal and allow for potential adjustment of electrolyte imbalances, as the patient's potassium level had risen to 5.8 mEq/L, posing a risk for cardiac arrhythmias. The decision to transition to CRRT required coordination with the intensive care team to ensure close monitoring of hemodynamic parameters and electrolyte levels, given the patient's precarious cardiac function.

Simultaneously, the cardiology team proceeded with plans for percutaneous coronary intervention (PCI) after discussing the risks and benefits with the patient and family. The angiography revealed significant stenosis in the left anterior descending artery, necessitating stent placement to restore adequate blood flow and mitigate further ischemic damage. Post-procedure, the patient's hemodynamic status showed slight improvement, with blood pressure stabilizing at 102/66 mmHg and heart rate moderating to 98 beats per minute. However, the team remained vigilant for potential post-procedural complications, emphasizing the need for ongoing assessment and timely intervention as the patient navigated this critical period.

Section 5

As the days progressed, the patient's response to the interventions was closely monitored. While the initiation of continuous renal replacement therapy (CRRT) had initially helped stabilize the patient's renal function, further complications arose. On the second day of CRRT, the patient began to exhibit signs of electrolyte imbalance. A repeat set of laboratory tests showed the potassium level had further increased to 6.2 mEq/L, despite the ongoing therapy. This hyperkalemia posed a significant risk of life-threatening arrhythmias, demanding urgent intervention. The nephrology team promptly adjusted the CRRT settings and administered a combination of calcium gluconate to stabilize cardiac membranes and insulin with glucose to facilitate intracellular potassium shift, illustrating the complexity of managing concurrent cardiac and renal issues.

Concurrently, the patient's respiratory status began to deteriorate. Auscultation revealed decreased breath sounds at the lung bases, and a chest X-ray confirmed the presence of mild pulmonary congestion, likely linked to fluid overload. This was reflected in a drop in oxygen saturation to 91% on room air, necessitating supplemental oxygen. The critical care team debated the potential need for non-invasive ventilation to support respiratory function and prevent further decompensation. Despite these challenges, the patient's cardiac output showed some improvement, as indicated by a slight reduction in peripheral edema and a heart rate now consistently below 100 beats per minute.

Balancing these evolving factors required careful clinical reasoning. The focus remained on maintaining hemodynamic stability while preventing further renal and respiratory complications. The interdisciplinary team convened to consider adjusting diuretic therapy to better manage fluid overload without compromising renal perfusion. This delicate balancing act underscored the importance of continuous re-evaluation of the patient's status, ensuring timely modifications to the treatment plan as new challenges emerged.